The financial lifeblood of a pathology group resides, in great part, in the efficiency of its billing operation. The level of billing complexity is directly proportional to the group’s size and complexity of its laboratory services offerings. Groups often struggle with whether to delegate such an important aspect of their financial health to an outside player or keep it in-house. Both options may offer advantages and disadvantages to the group. This round table discussion will explore elements critical to consider in deciding which billing setting is best for a pathology practice.
Karim E. Sirgi, MD, MBA, Chair Practice Management Committee
A. Joe Saad, MD, FCAP, CPE, Chairman of Pathology, Methodist Health System
Sang Wu, MD, Medical Director, North Dallas Pathology Services
Al Harrison Sirmon, Principal Pathology Practice Advisor